Amir Salek Farrokhi

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 5

Top Topics

Binding Protein

Helicobacter Pylori

Endoplasmic Reticulum Stress

Top Venues

Scandinavian journal of immunology

Journal of cellular physiology

Immunopharmacology and immunotoxicology

This page only lists publications with an associated author ORCID identifier.

Publications

Amirhossein Jahangiri, Rana Ezzeddini, Nazanin Zounemat Kermani, Fariborz Bahrami, Amir Salek Farrokhi
Combination of STAT3 inhibitor with Herceptin reduced immune checkpoints expression and provoked anti-breast cancer immunity: An in vitro study. Scandinavian journal of immunology 98 (3) (2023)
Amirhossein Jahangiri, Rana Ezzeddini, Nazanin Zounemat Kermani, Fariborz Bahrami, Amir Salek Farrokhi
Combination of STAT3 inhibitor with Herceptin reduced immune checkpoints expression and provoked anti-breast cancer immunity: An in vitro study. Scandinavian journal of immunology 98 (3) (2023)
Amir Salek Farrokhi, Narges Darabi, Bahman Yousefi, Rafee Habib Askandar, Mansoreh Shariati, Majid Eslami
Is it true that gut microbiota is considered as panacea in cancer therapy? Journal of cellular physiology (2019)
Bahman Yousefi, Maryam Mohammadlou, Maryam Abdollahi, Amir Salek Farrokhi, Mohsen Karbalaei, Masoud Keikha, Parviz Kokhaei, Saeid Valizadeh, Alireza Rezaiemanesh, Vahid Arabkari, Majid Eslami
Epigenetic changes in gastric cancer induction by Helicobacter pylori. Journal of cellular physiology 234 (12) (2019)
Hadi Askarifirouzjaei, Leila Khajoueinejad, Amir Salek Farrokhi, Mohammad Taher Tahoori, Mehdi Fazeli, Taki Tiraihi, Ali Akbar Pourfathollah
Implications of immunotherapy with high-dose glatiramer acetate in acute phase of spinal cord injury in rats. Immunopharmacology and immunotoxicology 41 (1) (2019)